Companies / BOC Sciences / Sontuzumab
BOC Sciences

Sontuzumab | BOC Sciences

Sontuzumab is a humanized monoclonal antibody directed against the tumor associated antigen (TAA) mucin-1 (MUC1). Sontuzumab binds to MUC1 expressed on the surface of tumor cells, which may activate the immune system to induce an antibody-dependent cellular cytotoxicity (ADCC) against MUC1-expressing tumor cells.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
  • See More